Aptevo Therapeutics Net Income 2014-2021 | APVO
For a detailed definition, formula and example for Net Income, check out our new background page here.
Aptevo Therapeutics net income from 2014 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Aptevo Therapeutics Annual Net Income
(Millions of US $) |
| 2020 |
$-18 |
| 2019 |
$-40 |
| 2018 |
$-54 |
| 2017 |
$7 |
| 2016 |
$-112 |
| 2015 |
$-59 |
| 2014 |
$-51 |
| 2013 |
$ |
Aptevo Therapeutics Quarterly Net Income
(Millions of US $) |
| 2021-09-30 |
$-7 |
| 2021-06-30 |
$-8 |
| 2021-03-31 |
$-7 |
| 2020-12-31 |
$-7 |
| 2020-09-30 |
$-7 |
| 2020-06-30 |
$-7 |
| 2020-03-31 |
$3 |
| 2019-12-31 |
$-8 |
| 2019-09-30 |
$-7 |
| 2019-06-30 |
$-13 |
| 2019-03-31 |
$-12 |
| 2018-12-31 |
$-14 |
| 2018-09-30 |
$-13 |
| 2018-06-30 |
$-13 |
| 2018-03-31 |
$-14 |
| 2017-12-31 |
$-10 |
| 2017-09-30 |
$38 |
| 2017-06-30 |
$-11 |
| 2017-03-31 |
$-10 |
| 2016-12-31 |
$-15 |
| 2016-09-30 |
$-72 |
| 2016-06-30 |
$-13 |
| 2016-03-31 |
$-13 |
| 2015-12-31 |
|
| 2015-09-30 |
$-13 |
| 2015-06-30 |
$-18 |
| 2014-12-31 |
|
| 2013-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.035B |
$0.004B |
|
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
|
